Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001004325 | SCV001163206 | pathogenic | Peroxisome biogenesis disorder 1A (Zellweger); Peroxisome biogenesis disorder 1B | criteria provided, single submitter | clinical testing | ||
Fulgent Genetics, |
RCV002497325 | SCV002805573 | pathogenic | Peroxisome biogenesis disorder 1A (Zellweger); Heimler syndrome 1; Peroxisome biogenesis disorder 1B | 2022-03-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002551711 | SCV003439987 | pathogenic | Zellweger spectrum disorders | 2022-03-26 | criteria provided, single submitter | clinical testing | This variant is also known as Nt2085-2089delGATAA (I696fs). This premature translational stop signal has been observed in individual(s) with Zellweger syndrome spectrum (PMID: 15542397, 16141001). This variant is present in population databases (rs267608178, gnomAD 0.003%). This sequence change creates a premature translational stop signal (p.Met695Ilefs*45) in the PEX1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PEX1 are known to be pathogenic (PMID: 9398847, 16086329, 16141001, 21031596, 26387595, 31831025). ClinVar contains an entry for this variant (Variation ID: 813403). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003473547 | SCV004203395 | pathogenic | Heimler syndrome 1 | 2023-12-23 | criteria provided, single submitter | clinical testing |